APA (7th ed.) Citation

JM, H., P, B., O, B., K, H., J, K., MJ, P., & V, N. (2025). Effect of EP395, a novel anti-inflammatory macrolide, in an inhaled lipopolysaccharide challenge model in healthy volunteers: A randomised controlled trial. Pulmonary pharmacology & therapeutics, 90, 102365. https://doi.org/10.1016/j.pupt.2025.102365

Chicago Style (17th ed.) Citation

JM, Hohlfeld, Badorrek P, Breuer O, Hanrott K, Kricker J, Parnham MJ, and Norris V. "Effect of EP395, a Novel Anti-inflammatory Macrolide, in an Inhaled Lipopolysaccharide Challenge Model in Healthy Volunteers: A Randomised Controlled Trial." Pulmonary Pharmacology & Therapeutics 90 (2025): 102365. https://doi.org/10.1016/j.pupt.2025.102365.

MLA (9th ed.) Citation

JM, Hohlfeld, et al. "Effect of EP395, a Novel Anti-inflammatory Macrolide, in an Inhaled Lipopolysaccharide Challenge Model in Healthy Volunteers: A Randomised Controlled Trial." Pulmonary Pharmacology & Therapeutics, vol. 90, 2025, p. 102365, https://doi.org/10.1016/j.pupt.2025.102365.